FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Sun Pharmaceutical Industries Amphotericin B Liposome for Injection Recall

Amphotericin B Liposome for Injection, 50mg vials, Rx only, Distributed by: Sun Pharmac…

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class II
Reported by FDA
May 15, 2024
Recall ID
D-0493-2024
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Amphotericin B Liposome for Injection starting Apr 19, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0493-2024 on May 15, 2024. Reason: Out of specification for assay. Status: Ongoing.

Why it was recalled

Out of specification for assay

Product description

Amphotericin B Liposome for Injection, 50mg vials, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti Halol-389350, Gujarat, India. NDC 62756-233-01

Lot numbers, UPCs & expiration codes

Lot #: BAE0055A, BAE0056A, BAE0068A, Exp. Date 03/2026

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0493-2024
Classification
Class II
Status
Ongoing
Recall initiated
Apr 19, 2024
FDA report date
May 15, 2024
Quantity
11,016 vials
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0493-2024, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
94442
Address
2 Independence Way
Code information
Lot #: BAE0055A, BAE0056A, BAE0068A, Exp. Date 03/2026
Postal code
08540-6620
Report date
May 15, 2024
Product type
Drugs
Recall number
D-0493-2024
Classification
Class II
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
11,016 vials
Reason for recall
Out of specification for assay
Voluntary / mandated
Voluntary: Firm initiated
Product description
Amphotericin B Liposome for Injection, 50mg vials, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti Halol-389350, Gujarat, India. NDC 62756-233-01
Distribution pattern
Nationwide within the United States
Recall initiation date
Apr 19, 2024
Initial firm notification
Letter
Center classification date
May 8, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0493-2024, published May 15, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls